Healthcare & Life Sciences
TearSolutions
United Statestearsolutions.com
TearSolutions is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
1
Investors
About TearSolutions
Based in the United States, TearSolutions is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
TearSolutions develops Lacripep, a proprietary topical peptide therapy derived from the tear protein Lacritin, intended to treat ocular surface diseases like dry eye by restoring tear film stability and improving corneal health.
Explore TearSolutions's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.